Works matching AU Lock, Michael

Results: 64
    1
    2
    3

    Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial.

    Published in:
    JAMA Neurology, 2022, v. 79, n. 6, p. 554, doi. 10.1001/jamaneurol.2022.0829
    By:
    • Knupp, Kelly G.;
    • Scheffer, Ingrid E.;
    • Ceulemans, Berten;
    • Sullivan, Joseph E.;
    • Nickels, Katherine C.;
    • Lagae, Lieven;
    • Guerrini, Renzo;
    • Zuberi, Sameer M.;
    • Nabbout, Rima;
    • Riney, Kate;
    • Shore, Svetlana;
    • Agarwal, Anupam;
    • Lock, Michael;
    • Farfel, Gail M.;
    • Galer, Bradley S.;
    • Gammaitoni, Arnold R.;
    • Davis, Ronald;
    • Gil-Nagel, Antonio
    Publication type:
    Article
    4

    Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial.

    Published in:
    JAMA Neurology, 2020, v. 77, n. 3, p. 300, doi. 10.1001/jamaneurol.2019.4113
    By:
    • Nabbout, Rima;
    • Mistry, Arun;
    • Zuberi, Sameer;
    • Villeneuve, Nathalie;
    • Gil-Nagel, Antonio;
    • Sanchez-Carpintero, Rocio;
    • Stephani, Ulrich;
    • Laux, Linda;
    • Wirrell, Elaine;
    • Knupp, Kelly;
    • Chiron, Catherine;
    • Farfel, Gail;
    • Galer, Bradley S.;
    • Morrison, Glenn;
    • Lock, Michael;
    • Agarwal, Anupam;
    • Auvin, Stéphane
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    An international survey on liver metastases radiotherapy.

    Published in:
    Acta Oncologica, 2012, v. 51, n. 5, p. 568, doi. 10.3109/0284186X.2012.681700
    By:
    • Lock, Michael I.;
    • Hoyer, Morten;
    • Bydder, Sean A.;
    • Okunieff, Paul;
    • Hahn, Carol A.;
    • Vichare, Anushree;
    • Dawson, Laura A.
    Publication type:
    Article
    15
    16
    17
    18

    Re: Deng and Heybati.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 1, p. 172, doi. 10.1093/jnci/djad229
    By:
    • Chow, Ronald;
    • Liu, Fei-Fei;
    • Haibe-Kains, Benjamin;
    • Lock, Michael;
    • Raman, Srinivas
    Publication type:
    Article
    19

    Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 Inaba.

    Published in:
    PLoS Neglected Tropical Diseases, 2019, v. 13, n. 11, p. 1, doi. 10.1371/journal.pntd.0007874
    By:
    • Hossain, Motaher;
    • Islam, Kamrul;
    • Kelly, Meagan;
    • Mayo Smith, Leslie M.;
    • Charles, Richelle C.;
    • Weil, Ana A.;
    • Bhuiyan, Taufiqur Rahman;
    • Kováč, Pavol;
    • Xu, Peng;
    • Calderwood, Stephen B.;
    • Simon, Jakub K.;
    • Chen, Wilbur H.;
    • Lock, Michael;
    • Lyon, Caroline E.;
    • Kirkpatrick, Beth D.;
    • Cohen, Mitchell;
    • Levine, Myron M.;
    • Gurwith, Marc;
    • Leung, Daniel T.;
    • Azman, Andrew S.
    Publication type:
    Article
    20

    Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor.

    Published in:
    Clinical Infectious Diseases, 2016, v. 62, n. 11, p. 1329, doi. 10.1093/cid/ciw145
    By:
    • Chen, Wilbur H.;
    • Cohen, Mitchell B.;
    • Kirkpatrick, Beth D.;
    • Brady, Rebecca C.;
    • Galloway, David;
    • Gurwith, Marc;
    • Hall, Robert H.;
    • Kessler, Robert A.;
    • Lock, Michael;
    • Haney, Douglas;
    • Lyon, Caroline E.;
    • Pasetti, Marcela F.;
    • Simon, Jakub K.;
    • Szabo, Flora;
    • Tennant, Sharon;
    • Levine, Myron M.
    Publication type:
    Article
    21
    22
    23
    24
    25
    26

    Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.

    Published in:
    PLoS Neglected Tropical Diseases, 2018, v. 12, n. 4, p. 1, doi. 10.1371/journal.pntd.0006376
    By:
    • Islam, Kamrul;
    • Hossain, Motaher;
    • Kelly, Meagan;
    • Mayo Smith, Leslie M.;
    • Charles, Richelle C.;
    • Bhuiyan, Taufiqur Rahman;
    • Kováč, Pavol;
    • Xu, Peng;
    • LaRocque, Regina C.;
    • Calderwood, Stephen B.;
    • Simon, Jakub K.;
    • Chen, Wilbur H.;
    • Haney, Douglas;
    • Lock, Michael;
    • Lyon, Caroline E.;
    • Kirkpatrick, Beth D.;
    • Cohen, Mitchell;
    • Levine, Myron M.;
    • Gurwith, Marc;
    • Harris, Jason B.
    Publication type:
    Article
    27
    28
    29

    Letrozole concentration is associated with CYP2A6 variation but not with arthralgia in patients with breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2018, v. 172, n. 2, p. 371, doi. 10.1007/s10549-018-4910-z
    By:
    • Borrie, Adrienne E.;
    • Rose, Rhiannon V.;
    • Choi, Yun-Hee;
    • Perera, Francisco E.;
    • Read, Nancy;
    • Sexton, Tracy;
    • Lock, Michael;
    • Vandenberg, Theodore A.;
    • Hahn, Karin;
    • Dinniwell, Robert;
    • Younus, Jawaid;
    • Logan, Diane;
    • Potvin, Kylea;
    • Yaremko, Brian;
    • Yu, Edward;
    • Lenehan, John;
    • Welch, Stephen;
    • Tyndale, Rachel F.;
    • Teft, Wendy A.;
    • Kim, Richard B.
    Publication type:
    Article
    30
    31

    A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): study protocol.

    Published in:
    BMC Palliative Care, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12904-024-01548-7
    By:
    • Palma, David A.;
    • Giuliani, Meredith E.;
    • Correa, Rohann J. M.;
    • Schneiders, Famke L.;
    • Harrow, Stephen;
    • Guckenberger, Matthias;
    • Zhang, Tina;
    • Bahig, Houda;
    • Senthi, Sashendra;
    • Chung, Peter;
    • Olson, Robert;
    • Lock, Michael;
    • Raman, Srinivas;
    • Bauman, Glenn S.;
    • Lok, Benjamin H.;
    • Laba, Joanna M.;
    • Glicksman, Rachel M.;
    • Nguyen, Timothy K.;
    • Lang, Pencilla;
    • Helou, Joelle
    Publication type:
    Article
    32

    A Phase 1 Two-Arm, Randomized, Double-Blind, Active-Controlled Study of Live, Oral Plasmid-Derived Adenovirus Type 4 and Type 7 Vaccines in Seronegative Adults.

    Published in:
    Vaccines, 2023, v. 11, n. 6, p. 1091, doi. 10.3390/vaccines11061091
    By:
    • Beaty, Shannon;
    • Collins, Natalie;
    • Karasavvas, Nicos;
    • Kuschner, Robert;
    • Hang, Jun;
    • Adhikari, Anima;
    • Maljkovic Berry, Irina;
    • Fung, Christian;
    • Walls, Shannon;
    • Betancourt, Elena;
    • Mendy, Jason;
    • Lock, Michael;
    • Gierman, Emma;
    • Bennett, Sean;
    • Shabram, Paul;
    • Warfield, Kelly
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50